The research aims to develop a model that predicts response to induction chemotherapy in nasopharyngeal carcinoma using MR radiomics.
Developed a cluster-specific MR radiomics model for nasopharyngeal carcinoma.
Analyzed MRI data to identify features relevant to treatment response.
Utilized quantitative imaging metrics to support prediction accuracy.
The model demonstrated reliable prediction of chemotherapy response.
It provided interpretable insights into which patients might benefit from treatment.
Abstract
The cluster 1-specific MR radiomics model reliably predicted the ICT response in NPC and may offer interpretable prognostic insights regarding treatment beneficiaries.